Cargando…
Stat3 Signaling Pathway: A Future Therapeutic Target for Bone-Related Diseases
Signal transducer and activator of transcription 3 (Stat3) is activated by phosphorylation and translocated to the nucleus to participate in the transcriptional regulation of DNA. Increasing evidences point that aberrant activation or deletion of the Stat3 plays a critical role in a broad range of p...
Autores principales: | Li, Jiadong, Yin, Zhifeng, Huang, Biaotong, Xu, Ke, Su, Jiacan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081430/ https://www.ncbi.nlm.nih.gov/pubmed/35548357 http://dx.doi.org/10.3389/fphar.2022.897539 |
Ejemplares similares
-
Bone-Targeted Nanoparticle Drug Delivery System: An Emerging Strategy for Bone-Related Disease
por: Chen, Yulin, et al.
Publicado: (2022) -
18β-Glycyrrhetinic Acid Inhibits Osteoclastogenesis In Vivo and In Vitro by Blocking RANKL-Mediated RANK–TRAF6 Interactions and NF-κB and MAPK Signaling Pathways
por: Chen, Xiao, et al.
Publicado: (2018) -
Bone Marrow Mesenchymal Stromal Cells: Identification, Classification, and Differentiation
por: Gao, Qianmin, et al.
Publicado: (2022) -
JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies
por: Rah, Bilal, et al.
Publicado: (2022) -
Pharmacological Effects of Polyphenol Phytochemicals on the JAK-STAT Signaling Pathway
por: Yin, Qianqian, et al.
Publicado: (2021)